Effects of sitagliptin on blood pressure and heart rate in response to intraduodenal glucose infusion in patients with Type 2 diabetes: a potential role for glucose-dependent insulinotropic polypeptide?

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To evaluate the effects of the dipeptidyl peptidase-4 inhibitor sitagliptin on blood pressure and heart rate, measured during a previously reported study, in which the effects of sitagliptin during intraduodenal glucose infusion at the rate of 2 kcal/min on glucose homeostasis were examined in patients with Type 2 diabetes.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Diabet Med

Title: Diabetic medicine : a journal of the British Diabetic Association

Publisher: Wiley

ISSN (Electronic): 1464-5491

ISSN (Print): 0742-3071

Publication date (Electronic): May 2015

Volume: 32

Issue: 5

Affiliations

[1 ] Discipline of Medicine, University of Adelaide, Adelaide, Australia; Centre of Research Excellence in Translating Nutritional Science to Good Health, University of Adelaide, Adelaide, Australia.

Article

DOI: 10.1111/dme.12622

PubMed ID: 25388434

SO-VID: 9a7350a3-9ac4-4297-b892-155898cb57f9

History

Data availability:

Comments

Comment on this article

scite_

Cited by 2

See all cited by